FIELD: medicine.
SUBSTANCE: method involves introducing drug of formula (I) where variables have known values shown in invention application.
EFFECT: increased treatment efficiency; reversed or prevented articular cartilage or subchondral bone degeneration.
10 cl, 10 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| SCHEME FOR USING FGF-18 COMPOUND | 2015 |
|
RU2700582C2 |
| SCHEME FOR USING FGF-18 COMPOUND | 2015 |
|
RU2691946C2 |
| SOLUTIONS AND METHODS FOR INHIBITING PAIN, CARTILAGE INFLAMMATION AND DESTRUCTION | 2000 |
|
RU2271825C2 |
| METHOD OF ESTIMATING INTENSITY OF DESTRUCTIVE PROCESSES IN CASE OF KNEE JOINT TRAUMATIC INJURY AND PREDICTION OF DEVELOPMENT OF POST-TRAUMATIC ARTHROSIS | 2011 |
|
RU2463000C1 |
| METHOD OF SIMULATING OSTEOARTHROSIS OF KNEE | 2011 |
|
RU2452999C1 |
| DIET COMPOSITION IN CASE OF OSTEOARTHRITIS IN DOGS | 2005 |
|
RU2351153C2 |
| IN-SITU SYSTEM FOR INTRA-ARTICULAR REGENERATION OF CARTILAGINOUS AND BONE TISSUES | 2007 |
|
RU2451527C2 |
| METHOD OF TREATMENT OF FULL-LAYER DEFECTS OF KNEE JOINT CARTILAGE WITH USE OF AUTOLOGOUS MESENCHYMAL STEM CELLS CULTURE | 2007 |
|
RU2351020C1 |
| COMPOSITION FOR TREATING AND PREVENTING OSTEOARTHRITIS AND OSTEOARTHROSIS | 2011 |
|
RU2509569C2 |
| COMPOSITION FOR TREATING AND PREVENTING OSTEOARTHRITIS, OSTEOPOROSIS AND OSTEOARTHROSIS | 2013 |
|
RU2521227C1 |
